75E-84022-23255
4 vaccinations
1 coded response
31 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 922 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
-
2020-12-27
Survey response — day 7, dose 1MedDRA: Menstruation irregular — Feeling: Good · Fatigue or tirednessFree text: Started menses earlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-10-12
Dose 4 — Pfizer-BioNTechCo-administered: Flu:Tetanus
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | Flu:Tetanus |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Started menses early
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release